The best time to ask questions about a study is before you agree to join it. A well-run study team expects questions and has answers ready; hesitation or vagueness in response to a reasonable question is itself useful information. You are not being difficult by asking — you are doing exactly what informed consent is designed to support.
Start with the basics of commitment. How long does the study run overall? How many visits are there, how long is each one, and how flexible are the appointment windows? Is anything required between visits, such as keeping a short daily log or using a product on a schedule? Knowing the real shape of the commitment prevents the most common reason people drop out, which is simple scheduling strain.
Ask what is actually being measured and how. You are entitled to understand, in ordinary language, what will be recorded about you, what the procedures involve, and what happens if you miss a step. If an explanation leans on jargon, ask for it again in plain words. Anything that cannot be explained simply has not been explained.
Cover compensation clearly. What is the amount, what is it based on, when is it paid, and what happens to compensation already earned if you leave the study early? Fair compensation recognizes your time, travel, and attention. It should be stated plainly up front, never framed as a reward for a particular result.
Ask how your information is handled. Who can see your records, how are they stored, how long are they kept, and what happens to your details once the study ends? It is also fair to ask how you will be contacted, and to say which methods you prefer. If you provided a phone number for updates, ask how to stop those messages whenever you want.
Finally, ask about your own exit. Confirm that participation is voluntary, that you can withdraw at any time without giving a reason, and who to contact if you have a concern during the study. Write the contact details down somewhere you will find them. A study you can comfortably leave is a study you can comfortably join.